Benzinga.com

Incyte's New Therapy Shows Signs Of 'Disease-Modifying' Potential In Rare Blood Cancer

Incyte Corporation (NASDAQ: INCY) on Sunday revealed new clinical data from two Phase 1 studies of INCA033989 for mutCALR-expressing myeloproliferative neoplasms (MPNs) at the 2025 American Society of ...
Business Wire

Incyte Announces New Positive Data for INCA033989, its First-In-Class mutCALR-Targeted Monoclonal Antibody, in Patients with Myelofibrosis Presented at ASH 2025

WILMINGTON, Del.--(BUSINESS WIRE)--Incyte (Nasdaq:INCY) today announced new clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class ...
The Fresno Bee

Tuberculosis cases increase in this Central Valley county. Here’s what you can do

Tulare County reports in November rise in active TB cases and exposure risk. Health officials urge risk-based TB screening via blood or skin tests in 2025. CDC logged an 8% US TB increase in 2024; ...
Morningstar

Blueprint Medicines, a Sanofi Company, Highlights Long-Term Clinical Benefit of AYVAKIT® (avapritinib) Across Indolent and Advanced Systemic Mastocytosis at 2025 ASH Annual ...

-- Durable disease control and quality-of-life improvements for patients with ISM in the PIONEER trial -- -- Prolonged survival, including in the first-line treatment setting, for patients with ...
SF Weekly

New tuberculosis case detected in Northern California. Here’s what to know

After an active case of tuberculosis was detected in the Sacramento area, you may be wondering about your risks of contracting the highly contagious disease. An individual with contagious tuberculosis ...